W
William C. Hahn
Researcher at Harvard University
Publications - 515
Citations - 85047
William C. Hahn is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 130, co-authored 448 publications receiving 72191 citations. Previous affiliations of William C. Hahn include Brigham and Women's Hospital & University of Washington.
Papers
More filters
Journal ArticleDOI
Open vs Robotic Radical Cystectomy Outcomes at a Single Institution: A Retrospective Review of 152 Patients
Ashley N. Gonzalez,Lee C. Zhao,Gary D. Steinberg,Anthony Corcoran,James S. Wysock,William C. Hahn +5 more
TL;DR: In this article , the authors performed a retrospective review of open vs robotic radical cystectomies performed at New York University (Manhattan and Long Island sites) between 2017 and 2022.
Proceedings ArticleDOI
Abstract 3992: Modes of metastasis evolution in human and murine cancer revealed by whole exome sequencing
Scott L. Carter,Priscilla K. Brastianos,David G. McFadden,Thales Papagiannakopoulos,Amaro Taylor-Weiner,Kristian Cibulskis,Tyler Jacks,William C. Hahn,Gad Getz +8 more
TL;DR: Evidence for the sequential spread of metastases is uncovered, consistent with multiregion sequencing of primary and metastatic human pancreatic cancer, and Modes of metastasis evolution in human and murine cancer revealed by whole exome sequencing are revealed.
Journal ArticleDOI
A Case of Persistent Helicobacter pylori Infection Occurring with Anti-IgE Immunosuppression.
TL;DR: This is the first case report linking an immunosuppressive regimen containing anti-IgE biologic therapy to persistent H. pylori infection, and it is reported that a patient receiving omalizumab failed to respond to antimicrobial therapy.
Proceedings ArticleDOI
Abstract PR04: A melanoma transcriptional state distinction influences sensitivity to MAPK pathway inhibitors
Cory M. Johannessen,David J. Konieczkowski,Omar O. Abudayyeh,Jong Wook Kim,Zachary A. Cooper,Adriano Piris,Dennie T. Frederick,Michal Barzily-Rokni,Ravid Straussman,Rizwan Haq,David E. Fisher,Jill P. Mesirov,William C. Hahn,Keith T. Flaherty,Jennifer A. Wargo,Pablo Tamayo,Levi A. Garraway +16 more
TL;DR: It is shown that RAF inhibitor sensitive and resistant BRAF V600 -mutant melanomas display distinct transcriptional profiles that suggest the transcriptional context in which an oncogenic event arises can have a profound impact on the establishment of oncogene-dependencies and associated drug susceptibilities.